Argument
Two of today's best-selling brands of full-strength prescription medication for the relief of excess stomach acid, Acid-Ease and Pepticaid, are now available in milder nonprescription form. Doctors have written 76 millions more prescriptions for full-strength Pepticaid. So people who need an effective but milder nonscription medication for he relief of excess stomach acid should choose Acid-Ease.
Answer
The argument that, in milder nonscription form, Acid-Ease is better chosen for excess stomach acid symptom than Pepticaid has not well discussed about several significant aspects. To be more convincing, the author of statement should provide and prove following topics.
Most obviously, The author lacks explaining why more sales of full-strength Pepticaid mean Acid-Ease is better than Peptocaid in nonprescription form. The more number of prescription in full-strength Pepticaid than Acid-Ease does not indicate that Acid-Ease is preferable in nonprescription form. Full-strength Pepticaid might have been sold more than Acid-Ease because it might be cheaper or more available than Acid-Ease. The author should clarify why Acid-Ease in nonprescription form is supported by a fact that Pepticaid has been prescribed 76 millions more than Acid-Ease.
Furthermore, there is no reason why Acid-Ease is better in nonprescription form than Pepticaid. Pepticaid could be even more effective than Acid-Ease to excess amount of stomach acid or could be even more affordable than Acid-Ease. To convince more readers of this argument, objective comparison of Pepticaid and Acid-Ease with their price, availability, and effectiveness must be concerned.
Finally, the author omits considering other rivals of nonprescription drug for excess stomach acid. Even though Pepticaid and Acid-Ease are top two best selling ones in prescription form for stomach acid, there could already be a giant in nonprescription form drug for stomach. Best selling model in prescription form does not directly lead to be best one in nonprescription form. The author must consider other models already existing in nonprescription form.
In conclusion, this argument still needs to develop itself in order to be more sound. Analyzing why Pepticaid has been prescribed much more than Acid-Ease, comparison between Pepticaid and Acid-Ease, and research of other drugs already expanding in nonprescription form should be addressed in this article.
